Schoolgirls to receive cervical cancer jabs

LONDON (Reuters) - Thousands of schoolgirls are to be vaccinated against the sexually transmitted virus that causes most cervical cancer cases as part of a national scheme starting this month, the NHS said on Monday.

All girls aged 12 or 13 will be offered the jab at school, while older teenagers will take part in a catch-up programme over the next year.

The NHS says the vaccine is most effective if it is given when girls are aged 12 or 13, before they start having sex.

Critics have described the injection as a “sex jab” that may encourage under-age sex and promiscuity.

However, Public Health Minister Dawn Primarolo said the routine vaccination of teenage girls against the human papillomavirus (HPV) is a crucial step that will save up to 400 lives a year.

Girls will need three doses of the drug over six months. Those aged 16 or over do not need their parents’ consent.

The vaccination programme for 12- to 13-year-olds will include around 300,000 girls across England each year.

By July 2011, including older girls vaccinated as part of the catch-up programme, over two million girls will have been offered the HPV vaccine.

One academic said the vaccination should also be offered to boys because they contribute to the transmission of the disease.

Dr Paul Yeo, of Durham University’s School of Medicine and Health, said: “By not vaccinating boys, we are potentially leaving a pool of infected individuals who could spread the viruses to women later.”

The Christian Institute, a religious charity, said schools should encourage children to abstain from underage sex, rather than give them the injections.

“It sends out completely the wrong message,” its director Colin Hart said in a statement on its website. “It is time to give our children their innocence back.”

Cervical cancer kills about 800 women each year in England and up to 300,000 globally, mostly in developing countries.

Women must still take regular smear tests to detect early signs of the cancer, which has a good cure rate if it is diagnosed early.

More information about the vaccine is on the NHS website at:

Reporting by Peter Griffiths; editing by Steve Addison